Related Experiment Video
Updated: Aug 9, 2026

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
Contribution of phospholipase C-beta3 phosphorylation to the rapid attenuation of opioid-activated phosphoinositide
D Strassheim1, P Y Law, H H Loh
1Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455-0347, USA.
Abstract:
Activation of the delta-opioid receptor in NG108-15 neuroblastoma X glioma hybrid cells results in a transient increase at the intracellular level of inositol-1,4,5-triphosphate [Ins(1,4,5)P3]. This time course in the transient increase in the Ins(1,4,5)P3 level is distinctly different from that observed in the homologous opioid receptor desensitization as measured by the inhibition of adenylyl cyclase activity. One probable mechanism for this rapid loss in Ins(1,4,5)P3 response is the feedback regulation of the phospholipase C activity. Regulation by protein phosphorylation was suggested by the observations that the opioid-mediated response was potentiated by calphostin C, an inhibitor of protein kinase C (PKC), and was abolished by either phorbol-12-myristate-13-acetate, a PKC activator, or calyculin A, a protein phosphatase1/2A inhibitor. The direct phosphorylation of phospholipase C was demonstrated by immunoprecipitation of PLC-beta3 from metabolically labeled NG108-15 cells challenged with the delta-selective agonist [D-Pen2, D-Pen5]enkephalin (DPDPE). A time- and DPDPE concentration-dependent and naloxone-reversible increase in the PLC-beta3 phosphorylation can be demonstrated. This PLC-beta3 phosphorylation was mainly due to PKC activation because pretreatment of NG108-15 cells with calphostin C could block the DPDPE effect. Activation of the PLC-beta3 by DPDPE was one of the prerequisites for agonist-mediated PLC-beta3 phosphorylation because the aminosteroid phospholipase C inhibitor U73122 could block the DPDPE effect. In addition to DPDPE, lysophosphatidic acid (LPA) stimulated the PLC-beta3 phosphorylation, but bradykinin did not. Furthermore, the LPA- and DPDPE-mediated PLC-beta3 phosphorylation was additive and was much less than that observed with phorbol-12-myristate-13-acetate. The effect of DPDPE was specific to PLC-beta3; the betagamma-insensitive phospholipase C-beta1 was not phosphorylated in the presence of either DPDPE or LPA. These results indicate that although PKC phosphorylation of PLC-beta3 is not obligatory for the opioid receptor desensitization, it seems to play a significant facilatory role in the mechanisms allowing desensitization of opioid-activated phospholipase C response before that of adenylyl cyclase inhibition.
Insights
Opioid receptor activation increases intracellular inositol-1,4,5-triphosphate (Ins(1,4,5)P3) but desensitizes via phospholipase C (PLC) phosphorylation. Protein kinase C (PKC) mediates this, facilitating opioid receptor desensitization.
Area of Science:
- Neuropharmacology
- Cell Signaling
- Molecular Biology
Background:
- Activation of delta-opioid receptors in NG108-15 cells transiently increases intracellular inositol-1,4,5-triphosphate (Ins(1,4,5)P3).
- The time course of this Ins(1,4,5)P3 increase differs from opioid receptor desensitization, suggesting feedback regulation of phospholipase C (PLC) activity.
Purpose of the Study:
- To investigate the mechanism of rapid loss in the Ins(1,4,5)P3 response following delta-opioid receptor activation.
- To determine the role of protein phosphorylation, specifically protein kinase C (PKC), in regulating PLC activity and opioid receptor desensitization.
Main Methods:
- Utilized NG108-15 neuroblastoma X glioma hybrid cells.
- Employed delta-selective opioid agonist [D-Pen2, D-Pen5]enkephalin (DPDPE) and other signaling molecules like lysophosphatidic acid (LPA).
- Investigated protein phosphorylation using immunoprecipitation of PLC-beta3 and assessed enzyme activity with inhibitors (calphostin C, U73122) and activators (phorbol-12-myristate-13-acetate).
Main Results:
- DPDPE stimulation led to time- and concentration-dependent phosphorylation of PLC-beta3, which was naloxone-reversible.
- PKC activation was responsible for DPDPE-mediated PLC-beta3 phosphorylation, as confirmed by calphostin C and phorbol ester treatments.
- DPDPE- and LPA-induced PLC-beta3 phosphorylation were additive, suggesting distinct but converging signaling pathways, and were specific to PLC-beta3.
Conclusions:
- PKC-mediated phosphorylation of PLC-beta3 plays a significant role in the desensitization of the opioid-activated phospholipase C response.
- This phosphorylation facilitates the desensitization of the PLC pathway preceding the desensitization of adenylyl cyclase activity following opioid receptor activation.
More Related Videos
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Amplifying Signals via Second Messengers
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...
IP3/DAG Signaling Pathway